Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 270 | 268 | 274 | 273 | 270 |
| Gross Profit | 270 | 268 | 274 | 273 | 270 |
| Operating Expenses | 3,045 | 2,827 | 3,918 | 3,028 | 2,971 |
| Operating Income | -2,775 | -2,559 | -3,644 | -2,755 | -2,701 |
| Other Income | 90 | 53 | 0 | -46 | 9 |
| Pre-tax Income | -2,685 | -2,506 | -3,644 | -2,801 | -2,692 |
| Net Income Continuous | -2,685 | -2,506 | -3,644 | -2,801 | -2,692 |
| Net Income | $-2,685 | $-2,506 | $-3,644 | $-2,801 | $-2,692 |
| EPS Basic Total Ops | -30.60 | -30.60 | -48.60 | -41.40 | -39.60 |
| EPS Basic Continuous Ops | -30.76 | -31.17 | -49.92 | -40.77 | -39.80 |
| EPS Diluted Total Ops | -30.60 | -30.60 | -48.60 | -41.40 | -39.60 |
| EPS Diluted Continuous Ops | -30.76 | -31.17 | -49.92 | -40.77 | -39.80 |
| EBITDA(a) | $-2,729 | $-2,491 | $-3,377 | $-2,675 | $-2,708 |